Showing results (71-80 of 77) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
The Lancet. Oncology|November 10, 2015
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trialChristoph Röllig, Hubert Serve, Andreas Hüttmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2019
Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International CohortsLinus Angenendt, Christoph Röllig, Pau Montesinos, et al.Blood Advances|November 18, 2021
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter studyJan M Middeke, Klaus H Metzeler, Christoph Röllig, et al.Blood Advances|November 6, 2024
Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemiaLeo Ruhnke, Marius Bill, Sven Zukunft, et al.Annals of Hematology|January 25, 2023
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group studyDietger Niederwieser, Thomas Lang, Rainer Krahl, et al.Leukemia|October 28, 2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patientsMarius Bill, Jan-Niklas Eckardt, Konstanze Döhner, et al.Blood|April 14, 2026
Inhibition of high CXCR4 with Motixafortide and absence of single-cell MRD predict outcome after AML consolidationEnise Ceran, Sonia Jaramillo, Anne Kathrin Merbach, et al.Pageof 8